Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Journal of Nuclear Medicine and Molecular Imaging
Literature
1.
Boellaard R, O'Doherty MJ, Weber WA, Mottaghy FM, Lonsdale MN, Stroobants SG, et al. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging 2009;37:181–200. doi:10.​1007/​s00259-009-1297-4.CrossRef
2.
Chawluk JB, Alavi A, Dann R, Hurtig HI, Bais S, Kushner MJ, et al. Positron emission tomography in aging and dementia: effect of cerebral atrophy. J Nucl Med 1987;28:431–7.PubMed
3.
4.
Basu S, Zaidi H, Houseni M, Bural G, Udupa J, Acton P, et al. Novel quantitative techniques for assessing regional and global function and structure based on modern imaging modalities: implications for normal variation, aging and diseased states. Semin Nucl Med 2007;37:223–39. doi:10.​1053/​j.​semnuclmed.​2007.​01.​005.CrossRefPubMed
5.
Alavi A, Newberg AB, Souder E, Berlin JA. Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators. J Nucl Med 1993;34:1681–7.PubMed
6.
Berkowitz A, Basu S, Srinivas S, Sankaran S, Schuster S, Alavi A. Determination of whole-body metabolic burden as a quantitative measure of disease activity in lymphoma: a novel approach with fluorodeoxyglucose-PET. Nucl Med Commun 2008;29:521–6. doi:10.​1097/​MNM.​0b013e3282f813a4​.CrossRefPubMed
7.
Larson SM, Erdi Y, Akhurst T, Mazumdar M, Macapinlac HA, Finn RD, et al. Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging: the visual response score and the change in total lesion glycolysis. Clin Positron Imaging 1999;2:159–71. doi:10.​1016/​S1095-0397(99)00016-3.CrossRefPubMed
8.
9.
Bural GG, Torigian DA, Burke A, Houseni M, Alkhawaldeh K, Cucchiara A, et al. Quantitative assessment of the hepatic metabolic volume product in patients with diffuse hepatic steatosis and normal controls through use of FDG-PET and MR imaging: a novel concept. Mol Imaging Biol 2009. doi:10.​1007/​s11307-009-0258-4.
Metadata
Title
Comment on: “FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging, version 1.0”
Authors
Babak Saboury
Drew A. Torigian
Abass Alavi
Publication date
01-07-2010
Publisher
Springer-Verlag
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 7/2010
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-010-1458-5

Other articles of this Issue 7/2010

European Journal of Nuclear Medicine and Molecular Imaging 7/2010 Go to the issue

Original Article

A HER2-binding Affibody molecule labelled with 68Ga for PET imaging: direct in vivo comparison with the 111In-labelled analogue

Image of the Month

‘Running on empty’

Original Article

Clinical value of FDG PET/CT in the diagnosis of suspected recurrent ovarian cancer: is there an impact of FDG PET/CT on patient management?

Focus on

PET-guided prostate cancer radiotherapy: technological innovations for dose delivery optimisation

Original Article

Clinical and survival impact of FDG PET in patients with suspicion of recurrent cervical carcinoma

Image of the Month

An unusual looking pacemaker infection imaged with 18F-FDG PET/CT